Knockdown of ADK decreases the methylation level of the VEGFR2 promoter region, which elevates intracellular adenosine and promotes proliferation, migration, and angiogenesis of human endothelial cells (Xu et al., 2017)—all aspects that may promote tumor growth. The gene discussed is ADK; the disease is neoplasm.